AAIS
ELV icon

ABN AMRO Investment Solutions’s Elevance Health ELV Stock Holding History

ABN AMRO Investment Solutions’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65M Buy
17,202
+6,109
+55% +$2.27M 0.06% 210
2026
Q1 		$3.25M Buy
11,093
+967
+10% +$318K 0.04% 261
2025
Q4 		$3.55M Buy
10,126
+7,856
+346% +$2.65M 0.05% 235
2025
Q3 		$733K Sell
2,270
-9,128
-80% -$2.84M 0.02% 315
2025
Q2 		$4.43M Sell
11,398
-2,584
-18% -$1.04M 0.09% 171
2025
Q1 		$6.08M Sell
13,982
-23,553
-63% -$9.45M 0.13% 140
2024
Q4 		$13.8M Sell
37,535
-236
-0.6% -$98.8K 0.26% 76
2024
Q3 		$19.6M Buy
37,771
+7,678
+26% +$4.1M 0.34% 65
2024
Q2 		$16.3M Sell
30,093
-400
-1% -$211K 0.3% 71
2024
Q1 		$15.8M Sell
30,493
-26,266
-46% -$13.1M 0.27% 74
2023
Q4 		$26.8M Sell
56,759
-969
-2% -$448K 0.47% 52
2023
Q3 		$25.1M Buy
57,728
+32,896
+132% +$14.9M 0.49% 52
2023
Q2 		$11M Buy
24,832
+3,222
+15% +$1.49M 0.22% 103
2023
Q1 		$9.94M Buy
+21,610
New +$10.3M 0.21% 109

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ABN AMRO Investment Solutions's ELV Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Elevance Health (ELV) stake by 55% in Q2 2026, buying an estimated $2.27M and bringing the position to 17,202 shares worth $6.65M. The position accounts for 0.06% of the portfolio, ranked #210.

ABN AMRO Investment Solutions first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $26.8M in Q4 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • ABN AMRO Investment Solutions held 17,202 shares of Elevance Health worth $6.65M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 6,109 Elevance Health shares in Q2 2026, an estimated $2.27M.
  • Elevance Health made up 0.06% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #210 holding.
  • ABN AMRO Investment Solutions first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's Elevance Health position peaked at $26.8M in Q4 2023.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.